Message From the President
To our current and future Sponsors:
Over our 25 year history, Medpace has steadfastly held to a model of providing full-service clinical development services to biopharmaceutical and medical device Sponsors. Even as the industry explored various outsourcing/insourcing models – functional, clinical staffing and hybrids – Medpace chose to drive success for Sponsors through full-service clinical trial outsourcing.
We know from our long-standing relationships with sponsors that the full-service outsourcing model ultimately delivers higher quality results.
When we can fully engage with our medical, regulatory and operational teams and work under our SOPs, we can perform at the highest levels to deliver quality results in the most timely and efficient manner. Competence and empowerment to coordinate all services under one roof provides an accountable, seamless, integrated and efficient platform – increasing quality and speed while significantly reducing a Sponsor’s need for duplicate management oversight.
I share my philosophy on full-service outsourcing with you because it has stood the test of time. I truly believe it is the best path for our Sponsors.
– August Troendle, MD, Medpace Founder and CEO since 1992
Discover the Power of X in Clinical Research and how Medpace can accelerate your drug and device development with our powerful combination of Experts, Experience, and Execution.
An Integrated Approach to Global Clinical Research
Integrating core clinical trial services delivers efficient and streamlined execution and higher quality results. Through its wholly-owned subsidiaries, Medpace offers clinical pharmacology, as well as supporting laboratory services including central laboratory, bioanalytical, ECG core lab, and imaging core labs.